首页> 外文期刊>The Thoracic and cardiovascular surgeon >Current Status of Off-pump Coronary Artery Bypass Grafting in Patients with Multiple Coronary Artery Disease Compared with On-pump Coronary Artery Bypass Grafting: The Korean National Cohort Study
【24h】

Current Status of Off-pump Coronary Artery Bypass Grafting in Patients with Multiple Coronary Artery Disease Compared with On-pump Coronary Artery Bypass Grafting: The Korean National Cohort Study

机译:多冠状动脉疾病患者的禁止冠状动脉旁路嫁接的现状与泵冠状动脉旁路嫁接相比:韩国国家队列研究

获取原文
获取原文并翻译 | 示例
       

摘要

Background Despite advance in off-pump coronary artery bypass (OPCAB) grafting, there are large debating issues regarding survival benefit between OPCAB and on-pump coronary artery bypass grafting (CABG). The aim of this study is to address appropriateness of OPCAB approach in patients with ischemic heart disease having multiple vessels using South Korea national cohort data. Methods To evaluate the safety and efficacy of OPCAB, we accessed all causes of death, late repeat revascularization, hospitalization for cerebrovascular accident (CVA), and new renal replacement therapy in patients who underwent isolated CABG with multiple grafting (≥2 grafts) and who were registered in the Korean Health Insurance Review and Assessment Service Database between April 2011 and September 2014. Results OPCAB was performed in 4,692 patients and on-pump CABG in 2,999 patients from 82 hospitals in South Korea. On multivariable analysis, on–pump CABG was associated with a significantly higher adjusted risk of overall all-cause death (hazard ratio [HR]: 1.876, 95% confidence interval [CI]: 1.587–2.216, p < 0.001) and initiation of new renal replacement therapy (HR: 1.618, 95% CI: 1.124–2.331, p = 0.009). However, we observed no significant difference in repeat revascularization and hospitalization for CVA between the two groups. In propensity score matching, matched patients (2,940 pairs) showed results similar to multivariable analysis that on-pump CABG was associated with a higher overall mortality and initiation of new renal replacement therapy ( p < 0.001). Conclusion In this study, we found that OPCAB was associated with better survival rates and renal preservation compared with on-pump CABG.
机译:背景技术尽管在泵浦冠状动脉旁路(OPCAB)嫁接中进行了进展,但有关OPCAB和泵浦冠状动脉旁路接枝(CABG)之间的生存益处存在大的辩论问题。本研究的目的是解决使用韩国国家队列数据的多艘船的缺血性心脏病患者的OPCAB方法的适当性。评估OPCAB的安全性和疗效的方法,我们访问了所有死亡的原因,晚期重复血运重建,脑血管事故(CVA)住院,以及多次接枝(≥2移植物)的患者进行患者的新肾置换疗法,以及谁在2011年4月至2014年4月至9月期间登记在韩国健康保险审查和评估服务数据库中。结果OPCAB在4,692名患者和南部南部82名医院患者中进行了次。在多变量分析上,泵车CABG与整体终原死亡的调整风险显着更高(危险比[HR]:1.876,95%置信区间[CI]:1.587-2.216,P <0.001)和启动新的肾脏替代疗法(HR:1.618,95%CI:1.124-2.331,P = 0.009)。然而,我们观察到两组之间的CVA重复血运重建和住院的重复差异没有显着差异。在倾向得分匹配中,匹配的患者(2,940对)显示出类似于多变量分析的结果,即泵车CABG与更高的总体死亡率和新的肾置换疗法引发有关(P <0.001)。结论在本研究中,我们发现,与泵上的CABG相比,OPCAB与更好的存活率和肾脏保存有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号